ArticleFrontiers in oncology2022

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.

FanJun Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.